Objectives: The aim of this study was to demonstrate a new clinically translatable ultrasound molecular imaging approach, modulated acoustic radiation forcebased imaging, which is capable of rapid and reliable detection of inflammation as validated in mouse abdominal aorta. Materials and Methods: Animal studies were approved by the Institutional Animal Care and Use Committee at the University of Virginia. C57BL/6 mice stimulated with tumor necrosis factor α, or fed with a high-fat diet, were used as inflammation (M Inflammation ) and diet-induced obesity (DIO) (M DIO ) models, respectively. C57BL/6 mice, not exposed to tumor necrosis factor α or DIO, were used as controls (M Normal ). P-selectin-targeted (MB P-selectin ), vascular cell adhesion molecule (VCAM)-1-targeted (MB VCAM-1 ), and isotype control (MB Control ) microbubbles were synthesized by conjugating anti-P-selectin, anti-VCAM-1, and isotype control antibodies to microbubbles, respectively. The abdominal aortas were imaged for 180 seconds during a constant infusion of microbubbles. A parameter, residual-to-saturation ratio (RSR), was used to assess P-selectin and VCAM-1. Statistical analysis was performed with the Student t test. Results: For the inflammation model, RSR of the M Inflammation + MB P-selectin group was significantly higher (40.9%, P < 0.0005) than other groups. For the DIO model, RSR of the M DIO + MB VCAM-1 group was significantly higher (60.0%, P < 0.0005) than other groups. Immunohistochemistry staining of the abdominal aorta confirmed the expression of P-selectin and VCAM-1. Conclusions: A statistically significant assessment of P-selectin and VCAM-1 in mouse abdominal aorta was achieved. This technique yields progress toward rapid targeted molecular imaging in large blood vessels and thus has the potential for early diagnosis, treatment selection, and risk stratification of atherosclerosis.
S
troke is the fourth leading cause of death in the United States and the direct and indirect cost of stroke was $33.6 billion in 2011. 1 Approximately 15% of stroke incidents are the result of emboli derived from carotid atherosclerosis. 2 The current standard of care for carotid atherosclerosis addresses the disease only after the plaque has developed. Detection is often achieved using anatomically based imaging modalities to measure the luminal stenosis. [3] [4] [5] However, luminal stenosis has been shown to be an inaccurate predictor of stroke risk. [6] [7] [8] Conversely, inflammatory responses of atherosclerosis progress silently for decades before plaque formation. 9, 10 Consequently, a method capable of imaging vascular inflammation would enable early diagnosis and risk assessment of atherosclerosis. 10 Molecular imaging could achieve this goal by directly visualizing the molecular markers, which are expressed on endothelial cells and associated with vascular inflammation. For example, P-selectin and vascular cell adhesion molecule-1 (VCAM-1) are markers associated with vascular inflammation. [10] [11] [12] Due to its favorable sensitivity, specificity, safety, cost, and availability, ultrasound molecular imaging has been implemented for the detection of vascular inflammation in preclinical studies. [13] [14] [15] Unfortunately, existing ultrasound molecular imaging, which is mainly based on either waiting period method 12 or the preburst minus postburst method, 13, 16 faces substantial challenges when applied in large blood vessels. 17, 18 The imaging procedure times are lengthy (30-40 minutes) due to multiple microbubble injections and long waiting periods ( Table 1) . The length and complexity of these imaging protocols could delay clinical adoption and increase procedure costs. Recently, a new ultrasound molecular imaging strategy, referred to as modulated acoustic radiation force (ARF)-based imaging, has demonstrated rapid (180 seconds) and quantitative measurements of molecular marker concentration in large vessels. [23] [24] [25] In this study, for the first time, we validated this technique for rapid assessment of P-selectin and VCAM-1 in the abdominal aorta of a murine model in just 180 seconds. The results demonstrate rapid and reliable targeted molecular imaging in a preclinical setting. The approach has potential, after considerable further development and validation, as a candidate for clinical usage. It has the potential for early and more accurate diagnosis of atherosclerosis. Although the mouse model involves vessels that are smaller in diameter with lower mean velocities than in human major arterial vessels, it should be borne in mind that the wall shear rate in a mouse is approximately 20-fold higher. 26 
MATERIALS AND METHODS

Mice Preparation
All animal studies were performed under a protocol approved by the Institutional Animal Care and Use Committee at the University of Virginia. The markers of P-selectin and VCAM-1 were selected for microbubble targeting within the abdominal aorta in C57BL/6 female mice (The Jackson Laboratory, Bar Harbor, ME). For the inflammation model, 10, 12 upregulation of P-selectin in mice (M Inflammation ) was achieved by intraperitoneal injection of tumor necrosis factor α (T7539; SigmaAldrich, St Louis, MO) approximately 2.5 hours before the start of imaging (0.5 μg/mouse). C57BL/6 mice (M Normal ), without any injections, were used as controls. For the DIO model, 27 30-week-old mice (M DIO ) were fed with a lard-based high-fat diet (HFD) (60% kcal fat, D12492; Research Diets, New Brunswick, NJ) from 6 weeks of age. Agematched control mice (M Normal ) were fed with a regular low-fat chow diet continuously.
Microbubble Preparation
Biotinylated microbubbles (average diameter = 2.2 μm, standard deviation of diameter = 1.5 μm, and resonance frequency ≈ 4.4 MHz) were synthesized using previously described methods. 28 ,29 P-selectin-targeted microbubbles (MB P-selectin ) were prepared by conjugating biotinylated monoclonal anti-P-selectin antibody (RB40.34, CD62P; BD Biosciences, San Diego, CA) to the microbubble using streptavidin linker (AnaSpec, Fremont, CA). 12, 30 Briefly, microbubbles were first subjected to repeated centrifugal wash in degassed normal saline to remove excess biotin-lipid, followed by the addition of streptavidin, another centrifugation, and addition of biotinylated antibody, followed by the final centrifugal wash. For the control microbubbles (MB Control ) used in the inflammation model, isotype control antibody (IgG1; BD Biosciences, San Diego, CA) was conjugated to the microbubble shell. For the VCAM-1-targeted microbubbles (MB VCAM-1 ), biotinylated monoclonal anti-VCAM-1 antibody (MVCAM.A, CD106; BD Biosciences, San Diego, CA) was conjugated to the microbubble shell. 30 For the control microbubbles (MB Control ) used in the DIO model, isotype control antibody (IgG2a; BD Biosciences, San Diego, CA) was conjugated to the microbubble shell. All the antibodies were added to the microbubbles at a concentration of 1.5 μg per 10 7 microbubbles to obtain maximal surface coverage (~10 5 antibody molecules per microbubble).
12
Modulated Acoustic Radiation Force-Based Imaging
The details of the modulated ARF-based beam sequence have been described in previous studies. 23, 24 Briefly, the sequence collected image data continuously for 180 seconds at a frame rate of approximately 6 Hz (Fig. 1A) . The signal intensity along the bottom wall of the abdominal aorta was detected and quantified. Residual-to-saturation ratio (RSR) was extracted from the signal intensity profiles. The microbubble dynamics in response to the modulated ARF-based beam sequence has been optically verified via microscopy. 25 The sequence was implemented on a programmable Verasonics ultrasound system (Vantage 256; Verasonics, Kirkland, WA) equipped with an L22-14v linear array transducer. The acoustic properties of both imaging and ARF pulses of the sequence are described in Table 2 .
In Vivo Imaging of Mice
The mice were initially anesthetized in the induction chamber using 2.5% isoflurane (Henry Schein, Dublin, OH). They were then transferred to a heated imaging stage (TM150; Indus Instruments, Webster, TX) and laid in the prone position (Fig. 1B ). They were kept under anesthesia (2% isoflurane) throughout the course of the experiment. Hair on the left side of the back was removed for imaging. A tail-vein catheter was affixed to administer the microbubbles while imaging. The location and orientation of the ultrasound transducer was carefully adjusted to obtain optimal images of the abdominal aorta (Fig. 1C) . The imaging depth (distance between transducer and bottom wall of abdominal aorta) ranged between 6 to 10 mm depending on the mouse body size. Different mice were used in each group to achieve independent measurements. Microbubbles were administered by constant infusion (50 Â 10 6 microbubbles in 150 μL sterile saline, infusion rate of approximately 2.5 Â 10 5 microbubbles/s) via the tail vein catheter using a syringe pump (PHD ULTRA; Harvard Apparatus, Holliston, MA). Imaging was performed approximately 20 seconds after the start of microbubble infusion.
Experimental Framework
The experiments were designed to have the mice and microbubble combinations illustrated in Table 3 .
Data Analysis
The region of interest (ROI) was located in the middle of bottom wall of the abdominal aorta. The following steps were used to reduce the effects of physiological motion on ROI location (Fig. 2) .
1 All image framesacquiredduring180secondsweresummedtogether.
2 A2mmÂ 0.8mm searching window on the bottom vessel wall was used to establish the ROI. 3 The area within the searching window with signal intensity higher than approximately 20% of the maximum intensity was defined as the ROI. The signal intensity curve of adherent microbubbles was calculated by averaging signal intensities within the ROI for all image frames. All signal intensity curves reported in this article were normalized, which was achieved by the following steps: during the 180-second imaging period, the minimum signal intensity was normalized to 0, and the maximum signal intensity was normalized to 1. All data analysis was performed in the MATLAB (MathWorks, Natick, MA) environment.
Immunohistochemistry Staining
Immunohistochemistry staining for P-selectin and VCAM-1 was performed on 5-μm-thick paraffin-embedded sections of the abdominal aorta for several mice in each group. 10 The antibodies used for immunohistochemistry were as follows: P-selectin (sc-6941; Santa Cruz Biotechnology, Dallas, TX) and VCAM-1 (sc-1504; Santa Cruz Biotechnology, Dallas, TX). The primary antibodies were detected using a Vectastain †Time for a complete measurement in format: time for control microbubble injection + waiting period for clearance + time for targeted microbubble injection = procedure time.
‡The P value between targeted group and various controls. §Waiting period for clearance of freely circulating microbubbles was not specified; estimated waiting period is 20 minutes. ∥Single injection of targeted microbubbles required; no waiting period. ARF indicates acoustic radiation force; CPS, contrast pulse sequences; PNP, peak negative pressure; MI, mechanical index.
Elite ABC Kit (Vector Laboratories, Burlingame, CA) after microwave treatment with Antigen Unmasking Solution (Vector Laboratories, Burlingame, CA). Visualization was performed with 3,3′-diaminobenzidine (DAB) chromagen (Acros Organics, Geel, Belgium). Counterstaining was performed using hematoxylin 1 (Richard-Allan Scientific, Kalamazoo, MI). Negative control experiments were performed by omitting the primary antibodies.
Statistics
All data were expressed as mean ± standard deviation. Statistical analysis was performed using the Statistics and Machine Learning Toolbox in MATLAB. An unpaired Student t test was used, and differences were considered statistically significant with a P value less than 0.05.
RESULTS
RSR Detected P-Selectin and VCAM-1 Markers with Statistical Significance
Representative signal intensity curves of the bottom vessel wall of the abdominal aorta from the groups of M Inflammation + MB P-selectin and M Normal + MB Control are illustrated in Figure 3 and Figure 4 , respectively. With targeted microbubbles, signal intensity increased with application of ARF and decreased to a residual level after cessation of ARF (Fig. 3) . With control microbubbles, signal intensity decreased to a lower level than the baseline after cessation of ARF (Fig. 4) .
The average signal intensities for the inflammation model are shown in Figure 5 . Solid lines indicate the mean and dotted lines indicate the error bars (mean ± standard deviation). Based on the normalization method described before, the values of average signal intensity curves were between 0 and 1. The initial values at 0 second varied depending on the lowest values during the 180-second imaging period. With the application of ARF, signal intensities increased in all groups. After the cessation of ARF, there was a residual intensity above the baseline only in the group of M Inflammation + MB P-selectin . For the other 3 groups, few adherent microbubbles remained attached on the vessel wall after the cessation of ARF. Due to the shadowing effects of freely circulating microbubbles, the residual intensities were lower than the baselines at 0 second. Residual-to-saturation ratio for the group of M Inflammation + MB P-selectin was 40.9%, significantly higher (P < 0.0005) than that of any other group (−239% for M Normal + MB Control , −74.9% for M Inflammation + MB Control , and −21.9% for M Normal + MB P-selectin ).
The average signal intensities for the DIO model are illustrated in Figure 6 . Residual-to-saturation ratio for the group of M DIO + MB VCAM-1 was 60.0%, significantly higher (P < 0.0005) than that of any other group (−94.9% for M Normal + MB Control , −13.9% for M DIO + MB Control , and −37.4% for M Normal + MB VCAM-1 ). Consequently, RSR could be used to detect P-selectin and VCAM-1 with statistical significance in inflammation and DIO models, respectively.
Immunohistochemistry Staining Confirmed Expression of P-Selectin and VCAM-1
Representative images of immunohistochemistry staining of the abdominal aorta are shown in Figure 7 . M Normal demonstrates minimal endothelial P-selectin staining (Fig. 7A) , whereas M Inflammation demonstrates P-selectin expression mostly localized to the luminal endothelial surface (Fig. 7B) . In addition, M Normal exhibits minimal endothelial VCAM-1 staining (Fig. 7C) , whereas M DIO exhibits VCAM-1 expression localized to the luminal endothelium (Fig. 7D) .
DISCUSSION
In this study, modulated ARF-based imaging was demonstrated to be effective for rapid assessment of P-selectin and VCAM-1 in the mouse abdominal aorta. Existing preclinical studies for detection of inflammation and atherosclerosis using ultrasound molecular imaging have been based mostly on traditional waiting period method 12 or preburst minus postburst method 13 without ARF (Table 1 ). However, in large blood vessels, relatively high shear forces necessitate the use of ARF to enhance microbubble targeting. 31 To reliably push microbubbles to the vessel wall in a human, we envision that it will be necessary to operate during the diastolic phase and rely on radiation forces that have been shown, using an extrapolation from an experimentally validated theory, to yield translation velocities up to 17 mm/s using acoustic intensities that are simultaneously Food and Drug Administration intensity compliant and microbubble nondestructive. 32 The use of ARF in this study reduces microbubble targeting time from a previous 3 to 10 minutes down to 1.5 minutes. In addition, the traditional method requires a second control microbubble injection and imaging to estimate the "nonspecific background." A waiting period (≥20 minutes) is required for clearance of previously injected microbubbles. These 2 extra steps can result in a complex imaging protocol and long imaging procedure time (30-60 minutes). In the new method, by monitoring the intensity level after cessation of ARF, RSR allows for quantification of the molecularly bound microbubbles and assessment of the density of molecular markers without any control injections. 23, 24 Consequently, a single targeted microbubble injection and imaging is sufficient to obtain measurements in only 180 seconds. The results demonstrated that RSR can be used to detect molecular markers with statistical significance in both inflammation and DIO models. Compared with other preclinical studies, 10, 11, [19] [20] [21] [22] our technique exhibited a very low P value (P < 0.0005) between the targeted group and various controls (Table 1) . Furthermore, the present study demonstrates that the measurements are insensitive to the imaging path length in vivo (ranged from 6-10 mm depending on mouse size). Consequently, RSR is a reliable and accurate indicator to assess P-selectin and VCAM-1 expression levels.
Limitations of the Study
The signal intensity curve in response to the modulated ARFbased imaging sequence was a result of both primary and secondary radiation forces. In this study, we did not elucidate the detailed mechanisms of the microbubble binding dynamics. A previous study 25 demonstrated that secondary radiation forces generate aggregates of adherent microbubbles with similar imaging sequences. More experiments would be required to examine the contributions of primary and secondary radiation forces, respectively. Although the proposed imaging technique has been demonstrated effective in vivo in this study, it will face challenges when applied in the clinical environments in the future. The algorithm may need to be optimized to account for the lower frequencies and greater depths in human. It may also require refinement to accommodate the presence of ultrasound artifacts (eg, clutter and reverberation). The effects of physiological motion have been reduced in the study. However, in clinical application settings, more advanced motion-correction methods are required to eliminate motion artifacts. In addition, this modulated ARF-based imaging technique could only detect molecular markers on the distal side of vessel wall relative to the transducer location. Consequently, effective detection of inflammation relies on the assumption that molecular markers for inflammation are approximately symmetrically distributed on the inner surface of blood vessels. In clinical applications, asymmetric distribution of molecular markers may significantly impact detection efficacy. Furthermore, the validation of this imaging technique was completed based on relatively simple flow profiles without complex flow patterns that include turbulence and backflow. As a result, more studies are required to demonstrate the robustness of this technique in realistic physiological conditions.
CONCLUSIONS
In conclusion, this ultrasound-based noninvasive technique could reliably and accurately detect molecular markers. It exhibits many desirable characteristics 1 : no separate control injections required 2 ; short protocol with a procedure time of 180 seconds and no extra waiting period 3 ; high detection specificity 4 ; imaging path length-insensitive measurements 5 ; and low-cost, radiation-free, clinical translatable, and ready for rapid adoption. This is the first in vivo validation of this technique to assess P-selectin and VCAM-1 expression in the abdominal aorta of a murine model. Significantly, this technique has the potential for clinical applications in large blood vessels for the early diagnosis, treatment selection, and risk stratification of atherosclerosis.
